EUVIMEDEUVIMED entdecken
Crossref

Spectrum of Pregnancy Outcomes in Systemic Lupus Erythematosus: A Three-Case Series Highlighting Diagnostic and Therapeutic Challenges

Samyuktha B S, Rajalekshmi M

International Journal of Drug Delivery Technology · 17.06.2026 · 16 (54s)

DOI: 10.25258/ijddt.16.54s.44 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 17.06.2026. Verfasst von Samyuktha B S und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pregnancy in women with systemic lupus erythematosus (SLE) carries substantial maternal and fetal risks, including disease flares, lupus nephritis, preterm birth, and haemorrhagic complications. We present a three-case series from a tertiary care teaching hospital illustrating the breadth of obstetric challenges encountered in SLE pregnancies. Case 1 describes a 35-year-old multigravida with known SLE and chronic hypertension who developed acute cervical shortening at 26 weeks (effective cervical length 6 mm), managed with an Arabin pessary, and subsequently required emergency lower segment caesarean section (LSCS) at 30 weeks for meconium-stained liquor, with the delivery complicated by refractory atonic postpartum haemorrhage (PPH) necessitating stepwise surgical escalation culminating in right internal iliac artery ligation. Case 2 describes a 25- year-old primigravida with a precious dichorionic diamniotic (DCDA) twin pregnancy conceived via intrauterine insemination (IUI), who was newly diagnosed with SLE (mucocutaneous involvement, strong anti-RNP/Sm positivity) and clinically labelled as having lupus nephritis on the basis of persistent nephrotic-range proteinuria, elevated blood pressure, and strongly positive serology — renal biopsy having been contraindicated by twin gestation. She was commenced on immunosuppressive therapy and delivered alive twin babies following emergency LSCS at 31+6 weeks for preterm premature rupture of membranes (PPROM) in the setting of an SLE flare. Case 3 describes a 21-year-old primigravida with biopsy-proven International Society of Nephrology/Renal Pathology Society (ISN/RPS) Class IV lupus nephritis who had failed sequential therapy with mycophenolate mofetil and rituximab without achieving remission, and who conceived at 4 weeks of gestation despite counselling against pregnancy. In the context of active uncontrolled nephritis, worsening renal failure, persistently elevated blood pressure, and concurrent teratogenic drug exposure, medical termination of pregnancy was performed for maternal safety. Together, these cases underscore the heterogeneity of SLE-related obstetric outcomes and the critical importance of pre-conception counselling, multidisciplinary surveillance, and tailored pharmacological management in this high-risk population.

Zitieren

APA

S, S. B., & M, R. (2026). Spectrum of Pregnancy Outcomes in Systemic Lupus Erythematosus: A Three-Case Series Highlighting Diagnostic and Therapeutic Challenges. International Journal of Drug Delivery Technology, 16(54s). https://doi.org/10.25258/ijddt.16.54s.44

Vancouver

S SB, M R. Spectrum of Pregnancy Outcomes in Systemic Lupus Erythematosus: A Three-Case Series Highlighting Diagnostic and Therapeutic Challenges. International Journal of Drug Delivery Technology. 2026;16(54s). doi:10.25258/ijddt.16.54s.44

BibTeX
@article{S2026,
  author = {S, Samyuktha B and M, Rajalekshmi},
  title = {Spectrum of Pregnancy Outcomes in Systemic Lupus Erythematosus: A Three-Case Series Highlighting Diagnostic and Therapeutic Challenges},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {54s},
  doi = {10.25258/ijddt.16.54s.44}
}
Kostenlos starten →